0001562180-24-003439.txt : 20240417 0001562180-24-003439.hdr.sgml : 20240417 20240417160157 ACCESSION NUMBER: 0001562180-24-003439 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240416 FILED AS OF DATE: 20240417 DATE AS OF CHANGE: 20240417 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Humer Kristian CENTRAL INDEX KEY: 0001872280 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39634 FILM NUMBER: 24850944 MAIL ADDRESS: STREET 1: C/O VIRIDIAN THERAPEUTICS, INC. STREET 2: 6200 LOOKOUT ROAD CITY: BOULDER STATE: CO ZIP: 80301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Foghorn Therapeutics Inc. CENTRAL INDEX KEY: 0001822462 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 TECHNOLOGY SQUARE STREET 2: SUITE 700 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-586-3100 MAIL ADDRESS: STREET 1: 500 TECHNOLOGY SQUARE STREET 2: SUITE 700 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 primarydocument.xml PRIMARY DOCUMENT X0508 4 2024-04-16 false 0001822462 Foghorn Therapeutics Inc. FHTX 0001872280 Humer Kristian 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 false true false false Chief Financial Officer false Stock Option (Right to buy) 6.03 2024-04-16 4 A false 275000.00 6.03 A 2034-04-15 Common Stock 275000.00 275000.00 D The option vests as to 25% of the underlying shares of common stock on April 16, 2025, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter until the option is fully vested. /s/ Michael LaCascia, Attorney-in-Fact for Kristian F. Humer 2024-04-17